OS appeared to be significantly decreased in the groups of patients with tumours harbouring TP53 mutations with diffuse Lauren type (p < 0.0085; Fig. 3a), with T3-T4 tumours (p = 0.037; Fig. 4b), and with stage III-IV tumours (p = 0.013; Fig. 5b). Here, TP53 is linked to neoplasm.